Evidence map›Paper›PMID 38892690›Full record

Trial reportNutrients2024

Efficacy of a Food Supplement Containing

Francesco Tursi, Edoardo Benedetto, Amelia Spina, Ileana De Ponti, Fabio Amone, Vincenzo Nobile

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Impact ofNutrients · 2024
    Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francesco TursiResearch and Development, Complife Italia S.r.l., 27028 San Martino Siccomario, Italy.ORCID 0000-0002-0055-5925
Edoardo BenedettoGIGA-CP Italian Association for Primary Care Gastroenterology, 87036 Rende, Italy.
Amelia SpinaNutratech S.r.l., Spin-Off of University of Calabria, 87036 Rende, Italy.
Ileana De PontiResearch and Development, Complife Italia S.r.l., 27028 San Martino Siccomario, Italy.ORCID 0000-0003-0579-7904
Fabio AmoneNutratech S.r.l., Spin-Off of University of Calabria, 87036 Rende, Italy.
Vincenzo NobileResearch and Development, Complife Italia S.r.l., 27028 San Martino Siccomario, Italy.ORCID 0000-0001-9147-302X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dietary interventions represent an interesting alternative to pharmacological treatments for improving the quality of life (QoL) of subjects suffering from gastroesophageal reflux disease (GERD). This randomized, double-blind, placebo-controlled study aimed to evaluate the efficacy of a food supplement (FS) containing a probiotic strain, bioactive peptides, and vitamins in relieving heartburn/dyspeptic symptoms in subjects with mild-to-moderate GERD. Fifty-six adult participants were randomly assigned to receive the placebo or the active FS for 28 days. Subjects were asked to record daily the frequency and intensity of heartburn episodes and the intake of over- the-counter (OTC) medications. GERD-QoL and self-assessment questionnaires were also completed every two weeks and at the end of the treatment, respectively. FS was effective in achieving a progressive and significant reduction of heartburn frequency and severity, with an intergroup significant difference at the end of the treatment period. FS group also reported a reduction in the OTC medication intake, whereas placebo administration did not modify the OTC intake. Results from the QoL and self-assessment questionnaires showed that FS administration achieved a progressive and statistically significant intragroup and intergroup improvement in the QoL score and a higher positive response with respect to the placebo treatment.

Indexed as

Dietary SupplementsGastroesophageal RefluxLactobacillus acidophilusPeptidesProbioticsQuality of LifeVitaminsAdultDouble-Blind MethodFemaleHeartburnHumansMaleMiddle AgedSeverity of Illness IndexSurveys and QuestionnairesPeptidesVitaminsbioactive peptidesclinical trialGERDprobioticsQoL

Identifiers

PMID38892690
PMCPMC11174755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.